By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
AmextaFinanceAmextaFinance
  • Home
  • News
  • Banking
  • Credit Cards
  • Loans
  • Mortgage
  • Investing
  • Markets
    • Stocks
    • Commodities
    • Crypto
    • Forex
  • Videos
  • More
    • Finance
    • Dept Management
    • Small Business
Notification Show More
Aa
AmextaFinanceAmextaFinance
Aa
  • Banking
  • Credit Cards
  • Loans
  • Dept Management
  • Mortgage
  • Markets
  • Investing
  • Small Business
  • Videos
  • Home
  • News
  • Banking
  • Credit Cards
  • Loans
  • Mortgage
  • Investing
  • Markets
    • Stocks
    • Commodities
    • Crypto
    • Forex
  • Videos
  • More
    • Finance
    • Dept Management
    • Small Business
Follow US
AmextaFinance > Investing > Nvidia, Micron, Joby Aviation, Carnival, and More Stock Market Movers
Investing

Nvidia, Micron, Joby Aviation, Carnival, and More Stock Market Movers

News Room
Last updated: 2023/06/29 at 1:35 PM
By News Room
Share
4 Min Read
SHARE

Stocks were mixed on Wednesday after Federal Reserve Chairman Jerome Powell said he wouldn’t take future consecutive rate hikes off the table “at all.”

These stocks made moves Wednesday: 

Nvidia
(ticker: NVDA) declined 1.8% and
Advanced Micro Devices
(AMD) fell 0.2% after The Wall Street Journal reported the Commerce Department could stop the shipments of AI chips made by the semiconductor makers to customers in China unless the companies first obtain a license. The restrictions could be put in place as early as next month, the Journal reported, citing people familiar with the situation. 

During an investor webinar Wednesday,
Nvidia
Chief Financial Officer Colette Kress said the company was aware the U.S. is considering further restrictions, but due to the level of strong demand for its products it doesn’t expect any “immediate material impact” to its results if the controls are adopted.

Micron Technology
(MU), which is scheduled to report quarterly earnings after the closing bell Wednesday, rose 0.4%. Other chip makers such as
Intel
(INTC) and
Qualcomm
(QCOM) traded lower.

Joby Aviation
(JOBY) soared 40% after the electric air taxi maker said it has received a special air-worthiness certificate from the Federal Aviation Administration for the first aircraft built at its pilot production line, which allows the company to start flight testing its first production prototype.

AST SpaceMobile
(ASTS) was falling 27% to $4.64 after announcing the launch of a sale of 12 million class A common shares.

Carnival
(CCL) rose 8.8% to $17.30 after Citi analysts boosted their price target on the cruise line company to $20 from $18. Other cruise companies were making gains, with
Royal Caribbean
(RCL) up 1.7% and
Norwegian Cruise Line Holdings
(NCLH) climbing 7.6%.

ZoomInfo
(ZI) gained 6.1% to $25.61 after shares of the corporate-information database company were initiated at Buy with a $35 price target by analysts at Needham.

Pinterest
(PINS) rose 6.6% to $28.13 after shares of the social media platform were raised to Overweight from Equal Weight at
Wells Fargo
and the price target was boosted to $34 from $23.

Snowflake
(SNOW) gained 3.9% after the cloud-based data warehousing company received a flurry of price target boosts from Wall Street firms. At its investor day on Wednesday, the company raised long-term operating margin and free cash flow margin guidance.

General Mills
(GIS) declined 5.2% after the food company reported a sharp decline in fiscal fourth-quarter profit and sales that missed analysts’ expectations.

Drone maker
AeroVironment
(AVAV) reported fiscal fourth-quarter revenue that beat analysts’ expectations and said it expects fiscal-year adjusted earnings of $2.30 to $2.60 a share on revenue of $630 million to $660 million, which also topped forecasts. The stock rose 4.9%.

The Food and Drug Administration rejected an application from
Regeneron Pharmaceuticals
(REGN) for approval of a new, higher-dose version of its blockbuster eye disease treatment Eylea. The stock fell 2.2% after declining 8.7% on Tuesday.

Regeneron said the FDA’s decision was “solely due to an ongoing review of inspection finding at a third-party filer” and Bloomberg reported that
Catalent
(CTLT) confirmed its Bloomington, Ind., site was the facility in question.
Catalent
shares tumbled 3.3%, and was one of the leading decliners in the
S&P 500.

Corrections & amplifications:  Regeneron Pharmaceuticals has a production facility in Bloomington, Ind. An earlier version of this article incorrectly said it was in Bloomberg,Ind.

Write to Joe Woelfel at [email protected]

Read the full article here

News Room June 29, 2023 June 29, 2023
Share this Article
Facebook Twitter Copy Link Print
Leave a comment Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Finance Weekly Newsletter

Join now for the latest news, tips, and analysis about personal finance, credit cards, dept management, and many more from our experts.
Join Now
Narendra Modi turns his focus to reforming India’s economy

India’s Prime Minister Narendra Modi gathered legislators from his ruling coalition in…

Why No Tax On Tips May Be Making America’s Tipping Problem Worse

Watch full video on YouTube

@AlexisOhanian: “We will absolutely see billion-dollar women’s sports teams.” 💰

Watch full video on YouTube

Jeffrey Epstein appointed Jes Staley and Lawrence Summers as executors of his will

Unlock the White House Watch newsletter for freeYour guide to what Trump’s…

We Saw Lucid’s Turnaround Plan And The Stakes Are Huge

Watch full video on YouTube

- Advertisement -
Ad imageAd image

You Might Also Like

Investing

Why Home Builders Are Bouncing Today—and Why Their Stocks Are Good Buys

By News Room
Investing

This Beaten-Down Industrial Stock Wants to Call America Home. Why It’s Time to Buy.

By News Room
Investing

These 8 Dividend Aristocrats Can Protect Your Portfolio in a Downturn

By News Room
Investing

Some Lenders Benefit From SBA’s Troubled Loan Program

By News Room
Investing

Social Security Is in Turmoil. Should You Lock In Benefits Now?

By News Room
Investing

Hims & Hers Stock Is Due for a Crash Diet. The GLP-1 Surge Is Fading Fast.

By News Room
Investing

Opinion: The stock-market selloff isn’t over yet. Here are 4 reasons why.

By News Room
Investing

With Trump’s tariffs paused, ‘Big Three’ automakers may race to build inventories

By News Room
Facebook Twitter Pinterest Youtube Instagram
Company
  • Privacy Policy
  • Terms & Conditions
  • Press Release
  • Contact
  • Advertisement
More Info
  • Newsletter
  • Market Data
  • Credit Cards
  • Videos

Sign Up For Free

Subscribe to our newsletter and don't miss out on our programs, webinars and trainings.

I have read and agree to the terms & conditions
Join Community

2023 © Indepta.com. All Rights Reserved.

YOUR EMAIL HAS BEEN CONFIRMED.
THANK YOU!

Welcome Back!

Sign in to your account

Lost your password?